Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Bristol-myers squibb company crawled date : 2021 - 09 - 16 save search
Ayala Pharmaceuticals Presents Preliminary Clinical Data from the Ongoing Phase 2 ACCURACY Trial and Announces Pre-Clinical Proof of Concept Data for Enhanced Activity of AL101 in Combination with Approved Cancer Therapies in ACC
Published: 2021-09-16 (Crawled : 14:00) - biospace.com/
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: -0.23%
H: 0.31%
C: -1.02%
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: 0.71%
H: 5.25%
C: -14.35%
phase 2 ongoing pre-clinical cancer proof of concept trial preclinical
5 Year Data from CheckMate -214 Show Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Longest Median Overall Survival Currently Reported in Phase 3 Trial of Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
Published: 2021-09-16 (Crawled : 12:00) - biospace.com/
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: -0.23%
H: 0.31%
C: -1.02%
media renal phase 3 trial cell carcinoma nivolumab
Exelixis Announces CABOMETYX® in Combination with OPDIVO® Provides Efficacy Benefits Regardless of Prior Nephrectomy in Patients with Previously Untreated Advanced Renal Cell Carcinoma Based on CheckMate -9ER Analysis Presented at ESMO 2021
Published: 2021-09-16 (Crawled : 09:00) - biospace.com/
TAK | $13.185 0.27% 570K
|
Health Technology
|
| O: 0.41%
H: 1.11%
C: 0.76%
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: -0.23%
H: 0.31%
C: -1.02%
EXEL | $22.965 0.42% 540K
|
Health Technology
|
| O: 0.0%
H: 0.83%
C: 0.34%
renal cell carcinoma
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
INVO | $1.36 78.95% 3.6M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
ALRN | $5.53 30.12% 250K
|
Health Technology
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.